Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
Authors:
- Thomas van GroenTGThomas van Groen
- Amanda J. KiliaanAKAmanda J. Kiliaan
- Inga KadishIKInga Kadish
- 1 September 2006
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 23 (3) , 653-662
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mouse Models of Alzheimer's Disease: Insight into TreatmentReviews in the Neurosciences, 2004
- The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s diseaseNeuroscience, 2001
- Co-expression of multiple transgenes in mouse CNS: a comparison of strategiesBiomolecular Engineering, 2001
- The Presenilins in Alzheimer's Disease--Proteolysis Holds the KeyScience, 1999
- Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's diseaseBrain Research, 1997
- Proteolytical processing of mutated human amyloid precursor protein in transgenic miceMolecular Brain Research, 1997
- A vector for expressing foreign genes in the brains and hearts of transgenic miceGenetic Analysis: Biomolecular Engineering, 1996
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- ßPP Participates in PrP-Amyloid Plaques of Gerstmann-Sträussler-Scheinker Disease, Indiana KindredJournal of Neuropathology & Experimental Neurology, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991